Investment House LLC decreased its position in Express Scripts Holding Company (NASDAQ:ESRX) by 25.5% during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 3,339 shares of the company’s stock after selling 1,141 shares during the period. Investment House LLC’s holdings in Express Scripts Holding were worth $213,000 as of its most recent filing with the SEC.

Several other large investors have also recently bought and sold shares of ESRX. Dubuque Bank & Trust Co. increased its stake in Express Scripts Holding by 53.1% in the first quarter. Dubuque Bank & Trust Co. now owns 1,753 shares of the company’s stock worth $116,000 after buying an additional 608 shares during the period. TrimTabs Asset Management LLC purchased a new stake in Express Scripts Holding during the first quarter worth $121,000. Capital Analysts LLC increased its stake in Express Scripts Holding by 5.6% in the first quarter. Capital Analysts LLC now owns 1,877 shares of the company’s stock worth $124,000 after buying an additional 100 shares during the period. IHT Wealth Management LLC increased its stake in Express Scripts Holding by 8.1% in the first quarter. IHT Wealth Management LLC now owns 1,944 shares of the company’s stock worth $128,000 after buying an additional 145 shares during the period. Finally, FNY Partners Fund LP purchased a new stake in Express Scripts Holding during the first quarter worth $138,000. 90.48% of the stock is owned by institutional investors.

Shares of Express Scripts Holding Company (NASDAQ:ESRX) traded down 0.040% during mid-day trading on Friday, hitting $62.575. The stock had a trading volume of 1,157,405 shares. The stock has a 50 day moving average of $63.15 and a 200-day moving average of $64.92. The stock has a market capitalization of $36.14 billion, a P/E ratio of 10.860 and a beta of 0.90. Express Scripts Holding Company has a 52 week low of $57.80 and a 52 week high of $77.61.

Express Scripts Holding (NASDAQ:ESRX) last released its quarterly earnings data on Tuesday, July 25th. The company reported $1.73 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.71 by $0.02. The firm had revenue of $25.35 billion for the quarter, compared to analyst estimates of $25.52 billion. Express Scripts Holding had a return on equity of 25.58% and a net margin of 3.50%. The business’s revenue for the quarter was up .5% compared to the same quarter last year. During the same quarter in the prior year, the company earned $1.57 earnings per share. On average, equities research analysts predict that Express Scripts Holding Company will post $6.99 earnings per share for the current year.

COPYRIGHT VIOLATION NOTICE: This piece of content was originally posted by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are reading this piece of content on another website, it was copied illegally and reposted in violation of US and international trademark and copyright legislation. The original version of this piece of content can be read at https://www.thecerbatgem.com/2017/08/04/investment-house-llc-sells-1141-shares-of-express-scripts-holding-company-esrx.html.

A number of research analysts recently weighed in on ESRX shares. Cowen and Company reissued an “outperform” rating and issued a $83.00 price objective on shares of Express Scripts Holding in a research note on Friday, June 9th. Morgan Stanley cut their price objective on Express Scripts Holding from $71.00 to $52.00 and set an “underweight” rating on the stock in a research note on Wednesday, April 26th. BidaskClub downgraded Express Scripts Holding from a “hold” rating to a “sell” rating in a research note on Wednesday, July 12th. Evercore ISI cut their price objective on Express Scripts Holding from $68.50 to $59.00 and set an “in-line” rating on the stock in a research note on Wednesday, April 26th. Finally, Mizuho cut their price objective on Express Scripts Holding from $76.00 to $61.00 and set a “neutral” rating on the stock in a research note on Tuesday, April 25th. Four research analysts have rated the stock with a sell rating, thirteen have given a hold rating, five have issued a buy rating and one has given a strong buy rating to the company. Express Scripts Holding presently has an average rating of “Hold” and an average price target of $70.81.

In other news, VP Phyllis S. Anderson sold 1,100 shares of the stock in a transaction that occurred on Friday, May 19th. The stock was sold at an average price of $60.08, for a total transaction of $66,088.00. Following the transaction, the vice president now owns 11,108 shares in the company, valued at $667,368.64. The sale was disclosed in a filing with the SEC, which is available through the SEC website. 0.68% of the stock is owned by corporate insiders.

About Express Scripts Holding

Express Scripts, Inc is a pharmacy benefit management (PBM) company in North America, offering a range of services to its clients, which include health insurers, third-party administrators, employers, union-sponsored benefit plans, workers’ compensation plans and government health programs. It operates in two segments: PBM and Emerging Markets (EM).

Want to see what other hedge funds are holding ESRX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Express Scripts Holding Company (NASDAQ:ESRX).

Institutional Ownership by Quarter for Express Scripts Holding (NASDAQ:ESRX)

Receive News & Stock Ratings for Express Scripts Holding Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Express Scripts Holding Company and related stocks with our FREE daily email newsletter.